Authentidate’s Telehealth Solution Featured in Nephrology News & Issues®
- Thursday, July 23, 2015
- Berkeley Heights, NJ
Authentidate Holding Corp. (Nasdaq: ADAT), a provider of web-based revenue cycle management applications and telehealth products and services for healthcare organizations was featured this month in an article in Nephrology News & Issues®, a publication that integrates the business and practice of quality kidney care.
The article, Renal Ventures Program to Start Remotely Monitoring Incident Dialysis Patients, written by Rebecca Zumoff, covered the recent announcement that Renal Ventures Management (RVM) would begin remotely monitoring a selection of their dialysis patients using Telehealth Solutions from Authentidate in an effort to decrease hospitalizations and mortality. Each dialysis patient in the program will be enrolled in a specific disease management protocol that will allow case managers to remotely manage and direct patient care.
Authentidate’s Telehealth Solution is designed to help patients achieve their goals to get healthy and stay healthy with an easy to use mobile device that captures vital signs, symptoms, and treatment plan compliance in the home and shares the associated data in real time with the patient’s care givers via the internet.
George R. Aronoff, MD, Chief Medical Officer of RVM told the publication, “Depending on their co-morbidities, patients may also be supplied with a glucometer, weight scale, BP cuff and oximeter that will record results back to the tablet via Bluetooth and then to a secure clinical portal website hosted by Authentidate. Our case managers and physicians then will access patient information from their PCs by logging on to the clinical portal. The case managers will also be able to interact with patients utilizing a camera on the tablets, if needed. Using remote patient management, we will be able to interact with these patients daily.”
Commenting on how patients were being selected he said, “We chose incident patients because, according to USRDS data, they have very high hospitalization and mortality rates.”
Aronoff also said they are also considering using the data that they collect to feed advanced decision support tools using predictive analytics to determine who among incident patients are the most at risk for hospitalizations and other adverse events.
The article can be read in its entirety at the following link: http://www.nephrologynews.com/renal-ventures-program-to-start-remote-monitoring-incident-dialysis-patients/
About Authentidate Holding Corp.
Authentidate Holding Corp. is a provider of web-based revenue cycle management applications and telehealth products and services that enable healthcare organizations to coordinate care for patients and enhance related administrative and clinical workflows. Authentidate’s products and services enable healthcare organizations to increase revenues, reduce costs and enhance patient care by eliminating paper and manual work steps from clinical and administrative processes. Authentidate’s telehealth solutions combine patient vital signs monitoring with a web application that streamlines patient care management. Delivered as Software as a Service (SaaS), customers only require an Internet connection and web browser to access our web-based applications thereby utilizing previous investments in systems and technology. The company’s healthcare customers and users include leading homecare companies, health systems, and physician groups. These organizations utilize the company’s products and services to coordinate care for patients outside of acute care.
For more information, visit www.authentidate.com
This press release contains forward-looking statements within the meaning of section 27A of the Securities Act of 1933 and section 21E of the Securities Act of 1934. When used in this release, the words “believe,” “anticipate,” “think,” “intend,” “plan,” “will be,” “expect,” and similar expressions identify such forward-looking statements. Such statements regarding future events and/or the future financial performance of the company are subject to certain risks and uncertainties, which could cause actual events or the actual future results of the company to differ materially from any forward-looking statement. Such risks and uncertainties include, among other things, the availability of any needed financing, the company’s ability to implement its business plan for various applications of its technologies, the impact of competition, the management of growth, and the other risks and uncertainties that may be detailed from time to time in the company’s reports filed with the Securities and Exchange Commission. In light of the significant risks and uncertainties inherent in the forward-looking statements included herein, the inclusion of such statements should not be regarded as a representation by the company or any other person that the objectives and plans of the company will be achieved.
Authentidate, Inscrybe and InscrybeMD are registered trademarks of Authentidate Holding Corp. All other trade names are the property of their respective owners.